We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UCB
3351
United Community Banks
UCB
$4.43B
$236K ﹤0.01%
6,982
+10
+0.1% +$363
VUSB icon
3352
Vanguard Ultra-Short Bond ETF
VUSB
$9.34B
$236K ﹤0.01%
+4,810
New +$235K
HIBB
3353
DELISTED
Hibbett, Inc. Common Stock
HIBB
$235K ﹤0.01%
3,452
-2,098
-38% -$131K
RSPS icon
3354
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$248M
$235K ﹤0.01%
6,890
-1,660
-19% -$55.6K
EGBN icon
3355
Eagle Bancorp
EGBN
$877M
$235K ﹤0.01%
+5,331
New +$241K
MXI icon
3356
iShares Global Materials ETF
MXI
$356M
$234K ﹤0.01%
2,980
PFI icon
3357
Invesco Dorsey Wright Financial Momentum ETF
PFI
$60.4M
$234K ﹤0.01%
5,750
-80
-1% -$3.32K
PRVB
3358
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$233K ﹤0.01%
22,082
+3,600
+19% +$29.1K
IVT icon
3359
InvenTrust Properties
IVT
$2.62B
$233K ﹤0.01%
+9,837
New +$235K
GXC icon
3360
State Street SPDR S&P China ETF
GXC
$469M
$233K ﹤0.01%
+2,971
New +$215K
ADUS icon
3361
Addus HomeCare
ADUS
$2.2B
$233K ﹤0.01%
+2,340
New +$245K
ANGO icon
3362
AngioDynamics
ANGO
$647M
$232K ﹤0.01%
16,839
-37,979
-69% -$528K
ZTO icon
3363
ZTO Express
ZTO
$17.4B
$231K ﹤0.01%
8,590
-24,731
-74% -$568K
YEXT icon
3364
Yext
YEXT
$613M
$231K ﹤0.01%
35,330
+4,765
+16% +$26K
NRK icon
3365
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$930M
$231K ﹤0.01%
22,471
+445
+2% +$4.47K
RBLD icon
3366
First Trust Alerian US NextGen Infrastructure ETF
RBLD
$58.5M
$230K ﹤0.01%
+4,755
New +$225K
GIB icon
3367
CGI
GIB
$15.5B
$230K ﹤0.01%
+2,666
New +$220K
SBIO icon
3368
ALPS Medical Breakthroughs ETF
SBIO
$214M
$229K ﹤0.01%
7,554
-1,847
-20% -$55.6K
BNFT
3369
DELISTED
Benefitfocus, Inc.
BNFT
$229K ﹤0.01%
21,858
-15,750
-42% -$141K
BSL
3370
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$170M
$228K ﹤0.01%
18,338
+2,295
+14% +$28.9K
FBGX
3371
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
$228K ﹤0.01%
602
-39
-6% -$15.5K
FCAP icon
3372
First Capital
FCAP
$219M
$227K ﹤0.01%
+9,121
New +$224K
FSP
3373
Franklin Street Properties
FSP
$46.4M
$227K ﹤0.01%
83,043
+36,145
+77% +$100K
RADI
3374
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
$226K ﹤0.01%
+19,159
New +$198K
IRT icon
3375
Independence Realty Trust
IRT
$4.01B
$226K ﹤0.01%
13,392
-1,336
-9% -$22.6K

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.